Patents Assigned to Alzheon, Inc.
  • Sulfopropanoic acid derivatives for treating neurodegenerative disorders
    Patent number: 12285400
    Abstract: Provided herein is the use of a compound of Formula (I): or a pharmaceutically acceptable salt thereof, for treating a disease characterized by amyloid and amyloid-like aggregates, e.g., Alzheimer's disease.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: April 29, 2025
    Assignee: Alzheon, Inc.
    Inventors: Petr Kocis, John Hey, Martin Tolar
  • Compositions and methods for treating and preventing neurodegenerative disorders
    Patent number: 12187668
    Abstract: Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: January 7, 2025
    Assignee: Alzheon, Inc.
    Inventors: Petr Kocis, Martin Tolar, John Hey
  • Methods for treating neurodegenerative disorders
    Patent number: 12083082
    Abstract: Tramiprosate and derivatives thereof are provided herein for treating neurodegenerative disorders such as Alzheimer's disease (AD).
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: September 10, 2024
    Assignee: Alzheon, Inc.
    Inventors: John Hey, Petr Kocis, Martin Tolar, Neil William Flanzraich
  • Methods for treating neurodegenerative disorders
    Patent number: 12036208
    Abstract: Methods of treating a disease characterized by amyloid aggregates are provided herein.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: July 16, 2024
    Assignee: Alzheon, Inc.
    Inventors: Petr Kocis, Martin Tolar, John Hey
  • Methods of treating neurodegenerative disorders in a particular population
    Patent number: 11191742
    Abstract: Disclosed herein are methods for treating, ameliorating, and/or preventing Alzheimer's Disease in a specific patient population using tramiprosate, valyl-3-amino-1-propanesulfonic acid, or a pharmaceutically acceptable salt thereof based upon a combination of APOE4 status and disease severity.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: December 7, 2021
    Assignee: Alzheon, Inc.
    Inventors: Susan Abushakra, Aidan Power, Martin Tolar, John Hey, Jeremy Yu, Petr Kocis
  • Methods for treating neurodegenerative disorders
    Patent number: 11077095
    Abstract: Methods of treating a disease characterized by amyloid aggregates are provided herein.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: August 3, 2021
    Assignee: Alzheon, Inc.
    Inventors: Petr Kocis, Martin Tolar, John Hey
  • Compositions and methods for treating and preventing neurodegenerative disorders
    Patent number: 11053192
    Abstract: Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.
    Type: Grant
    Filed: March 3, 2020
    Date of Patent: July 6, 2021
    Assignee: Alzheon, Inc.
    Inventors: Petr Kocis, Martin Tolar, John Hey
  • Compositions and methods for treating and preventing neurodegenerative disorders
    Patent number: 10590070
    Abstract: Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: March 17, 2020
    Assignee: Alzheon, Inc.
    Inventors: Petr Kocis, Martin Tolar, John Hey
  • METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20190374514
    Abstract: Methods of treating a disease characterized by amyloid aggregates are provided herein.
    Type: Application
    Filed: February 23, 2018
    Publication date: December 12, 2019
    Applicant: Alzheon, Inc.
    Inventors: Petr Kocis, Martin Tolar, John Hey
  • Methods for treating neurological disorders
    Patent number: 10471029
    Abstract: Disclosed herein are methods and compositions for treating, ameliorating, and/or preventing Alzheimer's disease in ApoE4-postitive patients using particular compounds and compositions thereof.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: November 12, 2019
    Assignee: Alzheon, Inc.
    Inventors: Martin Tolar, John A. Hey, Petr Kocis, Jeremy Yu